Lepu: bringing heart technology to lower tier cities

• Published 20 May 2010

The heart equipment specialist is in an unfortunate sweet spot as cardiovascular disease is urban China's biggest killer.

Background:Lepu Medical Technology (Beijing) Co (300003:ChiNext), a joint venture between China Shipbuilding Industry Corporation (CSIC) and WP Medical Technologies, produces devices used in the treatment of coronary heart disease such as coronary stent systems, dilatation catheters and central venous catheters among other products.

China Confidential Funds

China Confidential Funds, a new research service launched by FT China Confidential, is dedicated to illuminating the mainland fund industry. Our team of fund industry experts in Shanghai search out the interesting trends in fund performance, strategy, interactions with overseas funds, regulatory changes, distribution and management. We also use a proprietary system to track the emerging flows of Chinese money. Click here to find out more.

Other Articles on this Issue

• Financial China

  Is China headed for a perfect financial storm?

  Select financial charts

• Macro View

  A-share distress

• Consumer China

  Medical devices – in the pink

  Weigao: climbing the value chain

  Mindray: robust overseas sales

  Beijing Wandong: seeking solace in rural demand

  Shinva: on the acquisition trail

• Funds Data

  China flows go cold

• The Best of Chinese Commentators

  A-share slide

  Falling property prices to hurt local government finances?

• The Big Call

  Real estate prices start to fall

• Capital Intensive China

  Cooling property market to depress steel prices

• Guest Column

  China's new growth model – does it work?

• View issue